{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:09:54Z","timestamp":1784750994202,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejps.2026.107588","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:30:15Z","timestamp":1781713815000},"page":"107588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantitative image analysis reveals the benefits of dapagliflozin on glomerulosclerosis, podocyte effacement and kidney fibrosis in the SDT fatty rat model of diabetic nephropathy"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-6252","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Briand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Grasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgile","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Endlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Endlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Petitjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"de Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Sulpice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107588_bib0001","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2026.107588_bib0002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/abbs\/gmq129","article-title":"Texture analysis of liver fibrosis microscopic images: a study on the effect of biomarkers","volume":"43","author":"Amin","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ejps.2026.107588_bib0003","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fmed.2018.00292","article-title":"Comparative analysis of podocyte foot process morphology in three species by 3D super-resolution microscopy","volume":"5","author":"Artelt","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.ejps.2026.107588_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2017.142","article-title":"Modelling diabetic nephropathy in mice","volume":"14","author":"Azushima","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejps.2026.107588_bib0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.kint.2025.04.025","article-title":"Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models","volume":"108","author":"Bollinger","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2026.107588_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154707","article-title":"Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in golden Syrian hamsters","volume":"117","author":"Briand","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ejps.2026.107588_bib0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40620-023-01775-w","article-title":"Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions","volume":"37","author":"Cazzaniga","year":"2024","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejps.2026.107588_bib0008","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/cpt.3237","article-title":"Dapagliflozin reduces urinary kidney injury biomarkers in chronic kidney disease irrespective of albuminuria level","volume":"115","author":"Cho","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107588_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000492825","article-title":"The future: experimental therapies for renal disease in diabetes","volume":"143","author":"Fouli","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.ejps.2026.107588_bib0010","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/ijms21103587","article-title":"Revisiting experimental models of diabetic nephropathy","volume":"21","author":"Giralt-L\u00f3pez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107588_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1681\/ASN.2017040385","article-title":"Progressive renal disease established by renin-coding adeno-associated virus-driven hypertension in diverse diabetic models","volume":"29","author":"Harlan","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2026.107588_bib0012","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107588_bib0013","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-8587(21)00243-6","article-title":"Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Jongs","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ejps.2026.107588_bib0014","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/asj.12191","article-title":"Physiological changes induced by salt intake in female spontaneously diabetic Torii-Lepr(fa) (SDT fatty) rat","volume":"85","author":"Katsuda","year":"2014","journal-title":"Anim. Sci. J."},{"key":"10.1016\/j.ejps.2026.107588_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/363126","article-title":"Effects of unilateral nephrectomy on renal function in male spontaneously diabetic Torii fatty rats: a novel obese type 2 diabetic model","volume":"2014","author":"Katsuda","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejps.2026.107588_bib0016","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1538\/expanim.63.121","article-title":"Diabetic complications in obese type 2 diabetic rat models","volume":"63","author":"Katsuda","year":"2014","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejps.2026.107588_bib0017","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41598-024-55438-2","article-title":"Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model","volume":"14","author":"Kostadinova","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107588_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115670","article-title":"Podocyte injury of diabetic nephropathy: novel mechanism discovery and therapeutic prospects","volume":"168","author":"Li","year":"2023","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.ejps.2026.107588_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70098","article-title":"Tubular injury in diabetic kidney disease: early diagnosis and intervention strategies","volume":"41","author":"Lv","year":"2025","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ejps.2026.107588_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1538\/expanim.54.13","article-title":"A novel model of obesity-related diabetes: introgression of the Lepr(fa) allele of the Zucker fatty rat into nonobese spontaneously diabetic Torii (SDT) rats","volume":"54","author":"Masuyama","year":"2005","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejps.2026.107588_bib0021","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/srep02190","article-title":"Collagen morphology and texture analysis: from statistics to classification","volume":"3","author":"Mosta\u00e7o-Guidolin","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107588_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1677518","article-title":"Combined effect of esaxerenone and dapagliflozin on aldosterone-mediated sodium reabsorption and potassium excretion","volume":"16","author":"Nakamura","year":"2025","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejps.2026.107588_bib0023","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.3390\/ijms20235831","article-title":"Renal benefits of SGLT2 inhibitors and GLP-1 receptor agonists: evidence supporting a paradigm shift in the medical management of type 2 diabetes","volume":"20","author":"Nin\u010devi\u0107","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107588_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172537","article-title":"Nephropathy in diabetic db\/db mice is accelerated by high protein diet and improved by the SGLT2 inhibitor dapagliflozin","volume":"860","author":"N\u00f8rgaard","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107588_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2021.106453","article-title":"Blind color deconvolution, normalization, and classification of histological images using general super gaussian priors and Bayesian inference","volume":"211","author":"P\u00e9rez-Bueno","year":"2021","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.ejps.2026.107588_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70166","article-title":"Digital pathology quantification of the continuum of cirrhosis severity in human liver biopsies","volume":"45","author":"Petitjean","year":"2025","journal-title":"Liver Int."},{"key":"10.1016\/j.ejps.2026.107588_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2023.10.015","article-title":"Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions","volume":"80","author":"Ratziu","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejps.2026.107588_bib0028","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3748\/wjg.v24.i2.195","article-title":"INT-767 improves histopathological features in a diet-induced ob\/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis","volume":"24","author":"Roth","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2026.107588_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.33549\/physiolres.934533","article-title":"Glomerular hyperfiltration with hyperglycemia in the spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model","volume":"70","author":"Sano","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejps.2026.107588_bib0030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/ki.2011.31","article-title":"Transcutaneous assessment of renal function in conscious rats with a device for measuring FITC-sinistrin disappearance curves","volume":"79","author":"Schock-Kusch","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2026.107588_bib0031","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/1440-1681.13621","article-title":"Salt loading with unilateral nephrectomy accelerates decline in glomerular filtration rate in the hypertensive, obese, type 2 diabetic SDT fatty rat model of diabetic kidney disease","volume":"49","author":"Shinozaki","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejps.2026.107588_bib0032","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.kint.2025.01.040","article-title":"A new era in nephrology: the role of super-resolution microscopy in research, medical diagnostic, and drug discovery","volume":"107","author":"Siegerist","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2026.107588_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11553-x","article-title":"Structured illumination microscopy and automatized image processing as a rapid diagnostic tool for podocyte effacement","volume":"7","author":"Siegerist","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107588_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/616313","article-title":"New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy","volume":"2012","author":"Soler","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.ejps.2026.107588_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ackd.2005.01.008","article-title":"Tubular changes in early diabetic nephropathy","volume":"12","author":"Thomas","year":"2005","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.ejps.2026.107588_bib0036","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on diabetic nephropathy: core curriculum 2018","volume":"71","author":"Umanath","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2026.107588_bib0037","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3389\/fendo.2019.00700","article-title":"Dapagliflozin attenuates hyperglycemia related osteoporosis in ZDF rats by alleviating hypercalciuria","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejps.2026.107588_bib0039","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14728222.2019.1624721","article-title":"Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies","volume":"23","author":"Warren","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejps.2026.107588_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ejps.2026.107588_bib0041","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10157-020-02007-2","article-title":"Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats","volume":"25","author":"Yamada","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"issue":"Pt A","key":"10.1016\/j.ejps.2026.107588_bib0042","article-title":"Therapeutic efficacy of dapagliflozin on diabetic kidney disease in rats","volume":"113","author":"Yang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2026.107588_bib0043","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1038\/s41598-025-91278-4","article-title":"Dapagliflozin inhibits ferroptosis and ameliorates renal fibrosis in diabetic C57BL\/6J mice","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107588_bib0044","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1681\/ASN.2006070798","article-title":"Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice","volume":"17","author":"Zhao","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2026.107588_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmpb.2019.01.008","article-title":"Adaptive color deconvolution for histological WSI normalization","volume":"170","author":"Zheng","year":"2019","journal-title":"Comput. Methods Programs Biomed."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:24:41Z","timestamp":1784748281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0928098726001624"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107588","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative image analysis reveals the benefits of dapagliflozin on glomerulosclerosis, podocyte effacement and kidney fibrosis in the SDT fatty rat model of diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107588"}}